Leads To Development Joins Clarenta Group, Strengthening Early-Stage Drug Development Expertise

Summary

Leads To Development has joined Clarenta Group following a majority investment, enhancing Clarenta's capabilities in early-stage drug development and preclinical strategy support for biotech and pharmaceutical sponsors.